SMD Rise PCL (BKK:SMD100-R) Beneish M-Score: -2.34 (As of Jun. 26, 2026)


BKK:SMD100-R SMD Rise PCL BKK:SMD100-R
59 GF Score
Price ฿5.85
GF Value ฿23.66
! 6 Warning Signs
View Full Analysis

What is SMD Rise PCL Beneish M-Score?

SMD Rise PCL BKK:SMD100-R 59 Beneish M-Score is -2.34 as of Jun. 26, 2026. GuruFocus rates BKK:SMD100-R with a GF Score™ of 59/100 and a GF Value™ of ฿23.66. The stock has 6 warning signs investors should review. Among 113 Medical Distribution companies, SMD Rise PCL ranks worse than 67.26% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.34 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for SMD Rise PCL's Beneish M-Score or its related term are showing as below:

BKK:SMD100-R' s Beneish M-Score Range Over the Past 10 Years
Min: -4.57   Med: -2.55   Max: 0.97
Current: -2.34

During the past 8 years, the highest Beneish M-Score of SMD Rise PCL was 0.97. The lowest was -4.57. And the median was -2.55.


SMD Rise PCL Beneish M-Score Historical Data

* Premium members only.

The historical data trend for SMD Rise PCL's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SMD Rise PCL Beneish M-Score Chart

SMD Rise PCL Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -0.79 -3.01 -0.90 -2.48 -1.65

SMD Rise PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 -3.33 -2.82 -1.65 -2.34

BKK:SMD100-R vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, SMD Rise PCL's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMD Rise PCL Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where SMD Rise PCL's Beneish M-Score falls into.


BKK:SMD100-R
59GF Score
SMD Rise PCL BKK:SMD100-R
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SMD Rise PCL Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of SMD Rise PCL for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.123+0.528 * 1.1195+0.404 * 0.9918+0.892 * 1.1549+0.115 * 1.0355
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9807+4.679 * -0.020138-0.327 * 1.2624
=-2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ฿258.2 Mil.
Revenue was 172.712 + 252.75 + 344.426 + 160.892 = ฿930.8 Mil.
Gross Profit was 54.807 + 95.582 + 106.989 + 60.356 = ฿317.7 Mil.
Total Current Assets was ฿916.6 Mil.
Total Assets was ฿1,388.2 Mil.
Property, Plant and Equipment(Net PPE) was ฿264.9 Mil.
Depreciation, Depletion and Amortization(DDA) was ฿50.8 Mil.
Selling, General, & Admin. Expense(SGA) was ฿297.6 Mil.
Total Current Liabilities was ฿553.0 Mil.
Long-Term Debt & Capital Lease Obligation was ฿94.4 Mil.
Net Income was -30.544 + 21.6 + 29.244 + -13.756 = ฿6.5 Mil.
Non Operating Income was 0 + 0 + 8.617 + 0 = ฿8.6 Mil.
Cash Flow from Operations was 77.57 + -373.849 + 105.783 + 216.379 = ฿25.9 Mil.
Total Receivables was ฿199.1 Mil.
Revenue was 152.11 + 221.901 + 252.275 + 179.663 = ฿805.9 Mil.
Gross Profit was 51.337 + 93.362 + 98.006 + 65.299 = ฿308.0 Mil.
Total Current Assets was ฿856.6 Mil.
Total Assets was ฿1,227.1 Mil.
Property, Plant and Equipment(Net PPE) was ฿186.2 Mil.
Depreciation, Depletion and Amortization(DDA) was ฿37.2 Mil.
Selling, General, & Admin. Expense(SGA) was ฿262.8 Mil.
Total Current Liabilities was ฿387.7 Mil.
Long-Term Debt & Capital Lease Obligation was ฿65.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(258.173 / 930.78) / (199.067 / 805.949)
=0.277373 / 0.246997
=1.123

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(308.004 / 805.949) / (317.734 / 930.78)
=0.382163 / 0.341363
=1.1195

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (916.616 + 264.891) / 1388.218) / (1 - (856.606 + 186.219) / 1227.057)
=0.148904 / 0.150141
=0.9918

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=930.78 / 805.949
=1.1549

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(37.212 / (37.212 + 186.219)) / (50.77 / (50.77 + 264.891))
=0.166548 / 0.160837
=1.0355

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(297.604 / 930.78) / (262.758 / 805.949)
=0.319736 / 0.326023
=0.9807

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((94.394 + 552.964) / 1388.218) / ((65.507 + 387.745) / 1227.057)
=0.466323 / 0.369381
=1.2624

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(6.544 - 8.617 - 25.883) / 1388.218
=-0.020138

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

SMD Rise PCL has a M-score of -2.34 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.34 mean?
SMD Rise PCL (BKK:SMD100-R) has a Beneish M-Score of -2.34 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SMD Rise PCL and its competitors. According to the industry distribution chart, SMD Rise PCL ranks #76 out of 113 companies in the Medical Distribution industry, placing it in the top 67.3%.
Is SMD Rise PCL's Beneish M-Score too high?
SMD Rise PCL's current Beneish M-Score is -2.34. Based on the distribution chart, SMD Rise PCL ranks #76 out of 113 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #76 out of 113 companies for Beneish M-Score. This places SMD Rise PCL in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SMD Rise PCL and its competitors. SMD Rise PCL's current Beneish M-Score is -2.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Beneish M-Score of -2.34. The stock's GF Value™ is ฿23.66, compared to a current price of ฿5.85 — trading 75.3% below its estimated fair value. The current Beneish M-Score is -2.34. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Beneish M-Score is -2.34 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?

Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued. The current stock price of ฿5.85 is trading 75.3% below its estimated GF Value™ of ฿23.66.

Key valuation signals for BKK:SMD100-R:

  • Beneish M-Score: -2.34
  • GF Value™: ฿23.66 vs. price of ฿5.85 (75.3% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SMD Rise PCL Business Description

Other Exchanges SMD100:Thailand
Address 222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score

Get the complete analysis for BKK:SMD100-R

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.85
Price
฿23.66
GF Value